Cargando…
Treatment of Alzheimer’s disease across the spectrum of severity
Alzheimer’s disease (AD) is the most common cause of dementia affecting nearly 18 million people around the world and 4.5 million in the US. It is a progressive neurodegenerative condition that is estimated to dramatically increase in prevalence as the elderly population continues to grow. As the co...
Autores principales: | Shah, Shailaja, Reichman, William E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695170/ https://www.ncbi.nlm.nih.gov/pubmed/18044110 |
Ejemplares similares
-
Current pharmacologic options for patients with Alzheimer's disease
por: Reichman, William E
Publicado: (2003) -
Cascading network failure across the Alzheimer’s disease spectrum
por: Jones, David T., et al.
Publicado: (2016) -
The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2020) -
Regional brain stiffness changes across the Alzheimer's disease spectrum()
por: Murphy, Matthew C., et al.
Publicado: (2015) -
Degradation in intrinsic connectivity networks across the Alzheimer's disease spectrum
por: Nuttall, Rachel, et al.
Publicado: (2016)